Latest filing published 17 May 2022 for Abera Bioscience AB, €1,504.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Anders Ericsson: trading record in brief
This profile gathers the share dealings of Anders Ericsson in Abera Bioscience AB. In total, 5 filings cover trades dated from 20 January 2022 to 17 May 2022.
No open-market sale appears; the market trades are 5 purchases worth €26k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
In size, the median ticket on the buying side is €1,504. Clusters matter here: 4 out of 5 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The latest filing, published on 17 May 2022, reports an open-market purchase of €1,504 in Abera Bioscience AB. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. The regulation allows three business days to notify a trade (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Anders Ericsson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ SEK 7.936.0% of flowAktieISIN SE0015245097FI:csv-77eb38b53241b6c080b3Canonical exit: 11 Aug 2022 (T+90)
- 6,000 shares@ SEK 8.2018.7% of flowAktieISIN SE0015245097FI:csv-d526fcaad757e364d891Canonical exit: 14 Aug 2022 (T+90)
- 878 shares@ SEK 8.502.9% of flowAktieISIN SE0015245097FI:csv-6d604009208f78ff57f3Canonical exit: 15 Aug 2022 (T+90)
- 12,000 shares@ SEK 15.5872.4% of flowAktieISIN SE0015245097FI:csv-23432edbcce7aebb7eddCanonical exit: 20 Apr 2022 (T+90)
4 of 4 declarations